Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation
Plan to host Investor Day in 2026
Initiatives follow constructive engagement with Elliott Management
GALWAY, Ireland, Aug. 19, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the Medtronic Board of Directors has appointed John Groetelaars and Bill Jellison as independent directors, effective immediately.
Consistent with the company's commitment to shareholder value creation, and to provide enhanced focus and urgency around Medtronic's ongoing strategic portfolio management, operational improvement and capital allocation, the Board has formed the following special committees to align our governance with existing management focus areas and workstreams:
The Growth Committee will be responsible for guiding the evaluation and execution of growth-accretive tuck-in M&A, organic R&D investments, and potential divestitures, including the continued execution of the recently announced plan to separate its Diabetes business.
The Operating Committee will align governance with the company's initiatives to optimize operational performance, deliver margin expansion, and drive sustained earnings acceleration, including actions company management is taking to improve efficiency in its global manufacturing, supply chain, and operations.
Chief Executive Officer and Chairman of the Board, Geoff Martha, will serve as Chair of both of the newly formed committees, and newly appointed directors, Groetelaars and Jellison, will also serve on one or both of the committees.
"I am pleased to welcome John and Bill to the Medtronic Board of Directors – each of whom brings decades of relevant experience delivering growth as executives and directors of public companies in the medical technology industry. John's leadership managing global operations and Bill's deep financial expertise will also be valuable to the boardroom," said Geoff Martha, chairman and chief executive officer. "We are at an exciting inflection point and in a period of strong momentum, with multiple growth drivers already delivering and additional breakthrough therapies set to launch in the months ahead. With the addition of these new Board members and the formation of these two new committees, we are accelerating our strategic growth priorities and advancing the simplification and optimization of our operations. The separation of MiniMed is an example of the important steps we're taking to create a more focused and more profitable Medtronic. By sharpening our focus on high-margin growth opportunities, we are well-positioned to deliver stronger performance and greater value for patients, customers, and shareholders."
Medtronic will host an Investor Day in mid-calendar year 2026 at which the company will discuss the work of the Growth Committee and Operating Committee, including Medtronic's go-forward strategic priorities and financial algorithm.
Today's initiatives follow constructive dialogue with Elliott Investment Management L.P. ("Elliott").
Martha continued, "We appreciate our productive dialogue with Marc Steinberg and the Elliott team. The durable growth drivers now taking hold across several of our businesses are strengthening Medtronic's trajectory and reinforcing our conviction in the company's future. The Board believes Medtronic has the right strategies to build on this momentum and deliver sustained, superior returns for investors over the long-term."
Elliott Partner Marc Steinberg said, "Our decision to become one of Medtronic's largest investors was driven by our strong conviction that the company is entering a new chapter of exceptional value creation defined by accelerating growth, operational improvement and enhanced strategic clarity. We believe Medtronic's recent innovations in some of the medical technology sector's most attractive markets have positioned the company for an inflection in organic growth. Combined with its renewed focus on portfolio simplification and improved operational execution, Medtronic is set to deliver a sustainable acceleration in earnings growth as well. Today's announcements – including the addition of new directors with deep medical technology experience and the formation of two focused Board committees – are the right steps towards realizing Medtronic's potential. We look forward to continuing our constructive partnership with Geoff Martha and the Board and to working closely together to realize this unique value-creation opportunity."
Groetelaars and Jellison will be nominated to stand for election to the Board at Medtronic's 2025 Annual General Meeting of Shareholders.
New Board Member Biographies
John Groetelaars brings more than 30 years of global leadership experience across a broad range of medical device sectors. Most recently, Groetelaars served as interim CEO for Dentsply Sirona, having previously served in a director role for the company. Prior to Dentsply Sirona, John was President & CEO at Hillrom from May 2018 until the company's acquisition by Baxter International, Inc. in 2021. At Hillrom, he provided global leadership for a healthcare technology company with $3 billion in revenue and 10,000+ employees. Prior to joining Hillrom, Groetelaars served as executive vice president and president of the Interventional Segment at Becton, Dickinson and Company following its acquisition of C.R. Bard in December 2017.
Currently, Groetelaars serves as Chairman of the Board of Directors for Zeus Industrial Products. He is also a Board member for Parexel, a global clinical research organization.
Groetelaars earned a bachelor's degree in Mechanical Engineering from Kettering University and an MBA from Columbia University.
William Jellison is a former medical technology executive and corporate finance expert. From 2013 to 2016, he served as the Vice President, Chief Financial Officer of Stryker Corporation, a global leader in medical technologies. Before joining Stryker, Jellison spent 15 years at Dentsply International in several leadership positions, including CFO. Jellison began his career with the Donnelly Corporation, holding multiple financial management and executive roles, including Vice President of Finance, Treasurer and Corporate Controller.
Jellison currently serves as a Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and consults with other companies in the medical technology industry. He serves as a director of public companies Avient Corporation and Anika Therapeutics, Inc. as well as a director of private companies Solenis and Young Innovations.
Jellison received a B.A. in Business Administration from Hope College.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.
Contacts:
Erika Winkels
Public Relations
+1-763-526-8478
Ryan Weispfenning
Investor Relations
+1-763-505-4626
SOURCE Medtronic plc
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Think It's Too Late to Buy This Leading Industrials Stock? Here's the Biggest Reason Why There's Still Time
Key Points The company's revenue expectations keep improving through 2025. Only increased costs in connection with tariffs are holding back profit increases over the near term. 10 stocks we like better than Vertiv › The stock for data center infrastructure company and Nvidia partner Vertiv (NYSE: VRT) is trading up 84% since the end of March. That growth could continue as the company's underlying momentum is being masked by the effect of tariffs and an acceleration in investment to fuel future growth. Vertiv's quiet growth burst The table below shows the progression of its full-year guidance in 2025. Vertiv's sales guidance outstrips its adjusted operating profit increases. Profit growth is lagging sales growth due to extra costs associated with tariffs and the pull-forward of investment in research and development to fuel growth. Vertiv In February In April In July Increase in Guidance from February to July* Sales guidance $9.125 million to $9.175 million $9.325 million to $9.575 million $9.925 million to $10.075 million 8.7% Adjusted operating profit $1.910 million to $1.960 million $1.885 million to $1.985 million $1,950 million to $2.030 million 2.8% Free cash flow $1.275 million to $1.325 million $1.250 million to $1.350 million $1.375 million to $1.425 million 7.7% Data source: Vertiv, author's analysis. *All figures calculated assuming the midpoint of guidance. In usual circumstances, it's reasonable to expect a company's operating profit to expand more than its revenue growth. Margins should improve in a manufacturing company when it has larger volumes due to the benefits of scale, such as increased production efficiency and lower fixed cost per unit production. However, provided the tariff environment doesn't worsen for Vertiv, future orders and revenue increases are likely to translate into significant increases in profits and cash flow. Where next for Vertiv? Momentum continues to build in the data center end market, driven by torrid growth in artificial intelligence application demand. As such, Vertiv is in the early innings of a multi-year expansion in data center spending, and that includes its involvement in developing power systems and solutions for the next generation of data centers with Nvidia. Vertiv has a bright future, and it's not too late to invest in it. Should you invest $1,000 in Vertiv right now? Before you buy stock in Vertiv, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertiv wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,076% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.
The Market Online
6 hours ago
- The Market Online
@ the Bell: Economic crossroads: Inflation, earnings, and Powell's speech
Canada's main stock index slid lower on Tuesday, as investors awaited key inflation data that could influence expectations for a possible interest rate cut by the Bank of Canada. The Consumer Price Index (CPI) for July showed a 1.7 per cent year-over-year increase, slightly lower than June's 1.9 per cent. On a seasonally adjusted monthly basis, the CPI rose by 0.1 per cent in July. Meanwhile, US markets were divided as earnings reports from major retailers began to surface. Investors are also looking ahead to an important speech by Federal Reserve Chair Jerome Powell later this week, which could offer insights into future monetary policy. Wall Street is closely watching for signals from Powell regarding the Fed's remaining policy decisions for the year. Global central bank leaders will gather this week in Jackson Hole, Wyoming, for the Fed's annual economic symposium. Shares of Home Depot (NYSE:HD) finished trading more than 3 per cent higher after the company reported Q2 earnings that fell short of expectations, though it reaffirmed its full-year forecast. Reports from Lowe's (NYSE:LOW), Walmart (NYSE:WMT), and Target (NYSE:TGT) are expected later in the week. The Canadian dollar traded for 72.16 cents US compared to 72.42 cents US on Monday. US crude futures traded US$1.05 lower at US$62.37 a barrel, and the Brent contract lost $0.88 to US$66.72 a barrel. The price of gold was down US$15.11 to US$3,317.49. In world markets, the Nikkei was down 168.02 points to ¥43,546.29, the Hang Seng was down 53.95 points to HK$25,122.90, the FTSE was up 31.48 points to ₤9,189.22, and the DAX was up 108.30 points to €24,423.07. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here .
Globe and Mail
6 hours ago
- Globe and Mail
Nexa Announces Full Resumption of Operations at Cerro Pasco Complex
Luxembourg, Luxembourg--(Newsfile Corp. - August 19, 2025) - Nexa Resources S.A. (NYSE: NEXA) ("Nexa Resources", "Nexa" or the "Company") is pleased to announce the full resumption of operations at its Cerro Pasco Complex. The Atacocha and El Porvenir mines have resumed at normal capacity utilization levels following the cessation of illegal protests by a small group of individuals from the San Juan de Milpo community, which has restored access to the mines. The temporary and partial disruption resulted in an estimated zinc production loss of approximately 1.2kt of zinc. This volume is expected to be recovered in the upcoming month, and as previously disclosed, the Company's 2025 production guidance remains unchanged. Nexa reaffirms its commitment to maintaining constructive dialogue with local communities and authorities and to supporting the social and economic development of its host regions. About Nexa Nexa is a large-scale, low-cost, integrated polymetallic producer, zinc being our main product, with over 65 years of experience developing and operating mining and smelting assets in Latin America. Nexa currently owns and operates four long-life underground polymetallic mines, two located in the Central Andes region of Peru, and two located in Brazil (one in the state of Minas Gerais and one in the state of Mato Grosso). Nexa also owns and operates one low-cost polymetallic open pit mine, also in the Central Andes region of Peru, and three smelters, two located in the state of Minas Gerais in Brazil (Três Marias and Juiz de Fora), and one, located in Lima, which is Cajamarquilla, the largest smelter in the Americas. Nexa was among the top five producers of mined zinc globally in 2024 and one of the top five metallic zinc producers worldwide in 2024, according to Wood Mackenzie. Cautionary Statement on Forward-Looking Statements This news release contains certain forward-looking information and forward-looking statements as defined in applicable securities laws (collectively referred to in this news release as "forward-looking statements"). All statements other than statements of historical fact are forward-looking statements. The words "believe," "will," "may," "may have," "would," "estimate," "continues," "anticipates," "intends," "plans," "expects," "budget," "scheduled," "forecasts" and similar words are intended to identify estimates and forward-looking statements. Forward-looking statements are not guarantees and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Nexa to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments may be substantially different from the expectations described in the forward-looking statements for a number of reasons, many of which are not under our control, among them, the activities of our competition, the future global economic situation, weather conditions, market prices and conditions, exchange rates, and operational and financial risks. The unexpected occurrence of one or more of the abovementioned events may significantly change the results of our operations on which we have based our estimates and forward-looking statements. Our estimates and forward-looking statements may also be influenced by, among others, legal, political, environmental or other risks that could materially affect the potential development of our projects, including risks related to outbreaks of contagious diseases or health crises impacting overall economic activity regionally or globally, as well as risks relating to ongoing or future investigations by local authorities with respect to our business and operations and the conduct of our customers, including the impact to our financial statements regarding the resolution of any such matters. Our estimates and forward-looking statements may also be influenced by regulatory changes in the countries where we operate, including new trade restrictions, tariff escalations, and policy shifts affecting cross-border commerce and supply chains. Certain forward-looking statements are based on third-party data, market forecasts, and assumptions that may be subject to change. Nexa does not guarantee the accuracy of such external data and disclaims any obligation to update these statements unless required by law. These forward-looking statements related to future events or future performance and include current estimates, predictions, forecasts, beliefs and statements as to management's expectations with respect to, but not limited to, the business and operations of the Company and mining production, our growth strategy, the impact of applicable laws and regulations, future zinc and other metal prices, smelting sales, capex, expenses related to exploration and project evaluation, estimation of Mineral Reserves and/or Mineral Resources, mine life and our financial liquidity. Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable and appropriate by management and qualified persons considering their experience are inherently subject to significant uncertainties and contingencies and may prove to be incorrect. Statements concerning future production costs or volumes are based on numerous assumptions of management regarding operating matters and on assumptions that demand for products develops as anticipated, that customers and other counterparties perform their contractual obligations, full integration of mining and smelting operations, that operating and capital plans will not be disrupted by issues such as mechanical failure, unavailability of parts and supplies, labor disturbances, interruption in transportation or utilities, adverse weather conditions, and that there are no material unanticipated variations in metal prices, exchange rates, or the cost of energy, supplies or transportation, among other assumptions. We assume no obligation to update forward-looking statements except as required under securities laws. Estimates and forward-looking statements refer only to the date when they were made, and we do not undertake any obligation to update or revise any estimate or forward-looking statement due to new information, future events or otherwise, except as required by law. Estimates and forward-looking statements involve risks and uncertainties and do not guarantee future performance, as actual results or developments may be substantially different from the expectations described in the forward-looking statements. Further information concerning risks and uncertainties associated with these forward-looking statements and our business can be found in our public disclosures filed under our profile on SEDAR+ ( and on EDGAR (
